3D printed chitosan/polycaprolactone scaffold for lung tissue engineering: hope to be useful for COVID-19 studies
3D-печатный каркас из хитозана/поликапролактона для тканевой инженерии легких: потенциальное применение в исследованиях COVID-19
2021-01-01
SCID: 54.1/by9h83uf
Discuss with AI
3D-printed scaffoldCOVID-19 studiesMRC-5 cell culturechitosan/polycaprolactonelung tissue engineering
Figures from the paper
Abstract (AI)
. To sum up, scaffold 3 (chitosan/polycaprolactone ratio: 4 : 1) revealed better activity for MRC-5 cell culture. Thereby, this scaffold can be a good candidate for lung tissue engineering and may be applicable for more studies on the COVID-19 virus.
Key Findings
1
Among the tested formulations, scaffold 3 with a chitosan/polycaprolactone ratio of 4:1 showed the best activity in MRC-5 cell culture.
2
The 4:1 chitosan/polycaprolactone scaffold is identified as a potential candidate for lung tissue engineering.
3
The scaffold may support future studies involving COVID-19, although the abstract does not report direct antiviral or infection-related testing.
Research Object
3D-printed chitosan/polycaprolactone scaffold for lung tissue engineering
Research Subject
MRC-5 cell-culture activity of the chitosan/polycaprolactone scaffold, including its suitability as a lung-tissue-engineering candidate
Publication Details
Publication Date
2021-01-01
Journal
Publisher
ISSN
Cited by
61
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest